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varies, however, their specificity to rule in the infection is high.  29	
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Abstract 30	
Objective: The main objective of this systematic review of the literature was to determine the 31	
accuracy of on-site tests that require fewer resources to detect asymptomatic bacteriuria among 32	
pregnant women. 33	
Data source: We searched Medline, Embase, Web of Science, Scopus, and Latin-American 34	
Literature (LILACS) from inception until June 2015 without language restrictions. 35	
Methods of Study Selection: Two independent reviewers selected studies that recruited 36	
asymptomatic pregnant women to evaluate the accuracy of on-site tests in detecting the 37	
presence of bacteria in the urine using urine culture as a reference standard. 38	
Tabulation, Integration, and Results: Women’s characteristics, study design, urine sample 39	
collection and handling were extracted along with the test accuracy data. Where possible, we 40	
pooled the data using a bivariate, hierarchical random effects model. Of 1,360 screened 41	
references, 27 papers (13,641 women) with test accuracy data on nine tests met the inclusion 42	
criteria. The most commonly evaluated test was urine dipstick. The pooled sensitivity and 43	
specificity of nitrites detected by dipstick to detect asymptomatic bacteriuria were 0.55 (95% CI 44	
0.42 to 0.67) and 0.99 (95% CI 0.98 to 0.99), respectively. Griess test to detect nitrites had a 45	
sensitivity of 0.65 (95% CI 0.50 to 0.78) and specificity of 0.99 (95% CI 0.98 to 1·00). Dipslide 46	
with gram staining had a pooled sensitivity of 0.86 (95% CI 0.80 to 0.91) and specificity of 47	
0.97 (95% CI 0.93 to 0.99). 48	
Conclusions: The sensitivity of evaluated on-site tests to exclude bacterial urinary infection 49	
varies, however, their specificity to rule in disease is high. 50	
Registration number: PROSPERO No. CRD42015027905		51	
Keywords: test accuracy, asymptomatic bacteriuria, pregnancy, on-site test  52	
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Introduction  53	
Asymptomatic bacteriuria, a common urinary tract infection, varies in prevalence by factors 54	
such as age, gender, or level of sexual activity. The prevalence of the infection in pregnancy 55	
ranges from 2–15% of whom 20–40% progress to symptomatic urinary infections (UTI).1 56	
Pregnant women with undetected asymptomatic bacteriuria are more likely to deliver 57	
prematurely2 or low-birth-weight infants, and have a 20- 30-fold increased risk of developing 58	
pyelonephritis compared with those without the infection.3 59	
 60	
Although some bodies recommend a routine urine culture screening in early pregnancy4, 5, it is 61	
an expensive, cumbersome, and time-consuming test (taking 24 to 48 hours to obtain results) 62	
that requires access to laboratory facilities. There is a wide range of tests requiring fewer 63	
resources and minimal training,6 of which the most commonly used to detect the presence of 64	
bacteria instantly in the urine is a dipstick. Available evidence synthesis on their accuracy in 65	
pregnancy is limited in range of evaluated test7, and methodological strength.6, 8 66	
 67	
We bridge the above gap through a systematic and comprehensive evaluation of a wide range of 68	
on-site tests used to detect bacteriuria compared against urine culture as a reference standard in 69	
asymptomatic pregnant women taking into account potential sources of heterogeneity. 70	
 71	
Methods 72	
The review was conducted prospectively guided by a pre-defined protocol (PROSPERO No. 73	
CRD42015027905). We followed current standards of evidence synthesis for test accuracy9-11 74	
and reported findings in compliance with guidelines.12 75	
 76	
Sources 77	
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We searched major databases such as Medline, Embase, Web of Science, Scopus, and a 78	
specialized database of Latin-American literature (LILACS) for studies published from 79	
database inception to August 2014, with no language restrictions. The search was updated to 80	
June 2015 and was supplemented by a hand search of the references from the included 81	
publications. The search strategy combined terms such as: ‘Pregnancy’, ‘Antenatal’, 82	
‘Gestation’, ’asymptomatic bacteriuria’ and ‘Urinary Tract Infections’ and applied a filter for 83	
test accuracy studies (for details see Appendix 1).13 The ClinicalTrials.gov register database 84	
was screened to identify any recently completed studies. 85	
 86	
Study selection 87	
Two independent reviewers (ER and SF) screened references and full-text of previously 88	
selected articles. The consensus on the eligibility of evaluated publications was reached through 89	
discussion, or consultation with a third reviewer (KSK). We looked for studies reporting the 90	
accuracy of any on-site tests to detect asymptomatic bacteriuria among pregnant women 91	
without symptoms of urinary tract infections or not on antibiotic treatment. The reference 92	
standard had to be a urine culture, and asymptomatic bacteriuria had to be defined as equal, or 93	
more than 105 Colony Forming Units of a single organism per mL of urine.8 Test accuracy had 94	
to be reported in a way allowing construction of 2 x 2 tables. We excluded studies with a case-95	
control design and were reference standard was not reported or used a different definition of 96	
bacteriuria than specified above as this design and variation in reference standard were 97	
associated with bias.14 98	
 99	
Data were extracted independently by ER and SF on to a piloted sheet. We collected authors’ 100	
details, year of publication, country, women’s characteristics, gestational age at testing; urine 101	
collection method, storage, and handling. The data were tabulated, crossed checked and in the 102	
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case of discrepancies discussed between the reviewers. The studies were grouped according to 103	
country income (low-, low-middle, upper-middle) using the World Bank classification.15 The 104	
risk of bias and applicability of included studies were assessed by two independent reviewers 105	
(ER and SF) using the QUADAS-2 tool10 tailored for this review. Study quality was assessed 106	
for selection of participants, implementation of the index test and the reference standard, and 107	
patient flow. Studies with low risk of bias used a suitable spectrum of participants, recruited in 108	
consecutive or random manner; all participants were tested using the same reference standard, 109	
and the majority of the study population was included in analyses. Any disagreements over 110	
quality assessment were resolved by a third reviewer (KSK). We did not assess publication bias 111	
due to limitations of available methods.16, 17 112	
 113	
We calculated test accuracy estimates (sensitivity, specificity, and likelihood ratios for positive 114	
and negative test result) with 95% confidence intervals (CIs). Heterogeneity was investigated 115	
visually on forest plots with sensitivity and specificity estimates (with 95% confidence 116	
intervals) for individual studies. The impact of quality of study design, the reliability of 117	
population description, and sample collection and storage was explored through sensitivity 118	
analyses. All analyses were conducted using STATA version 12.1.18 If less than required 119	
number of data points was available, we pooled accuracy of sensitivity and specificity, and 120	
likelihood ratios using univariate model using metaprop and metan commands, respectively. 121	
Where a higher number of studies was available, we pooled the accuracy parameters using 122	
bivariate, random effects model as implemented in metandi19 and midas20 commands . Posttest 123	
probabilities were calculated using following formula: O= p1/(1 - p1 ), p2 = O * L, p = p2 /(1 + 124	
p2), where p1 pretest probability, O pretest odds, p2 posttest odds, L likelihood ratio, p posttest 125	
probability.21  126	
 127	
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Results 128	
Out of the 1,360 references, 39 examining 27 types of index tests appeared initially to meet the 129	
inclusion criteria (Figure 1). After exclusion of tests not suitable for use in the asymptomatic 130	
population, we were left with 27 studies with nine index tests. List of all identified tests and 131	
reasons for study exclusion can be found in Appendix 2. Selected tests were: dipstick with only 132	
nitrites marker as positive, dipstick with nitrites or leucocytes as positive, urine analysis with 133	
bacteria count, dipslide with gram stain, Uricult (Orion Diagnostica, Espoo, Finland), 134	
Microstix-3 (Bayer Schering Pharma, Berlin, Germany), Griess test to detect nitrites, 135	
chlorhexidine reaction, and uriscreen catalase test. Reference of the included studies can be 136	
accessed in Appendix 3. 137	
 138	
The majority of identified studies were conducted in low-middle (11 studies) or upper-middle 139	
(five studies) income countries; ten in high-income countries and only one in a low-income 140	
country. The studies were published between 1981 and 2015; ten studies were published before 141	
the year 2000, nine between 2000 and 2010 and remaining eight in the last five years. The 142	
majority (19/27) of included studies contributed to evidence synthesis accuracy data of only 143	
one test (Table 1) with urine dipstick as the most commonly reported test. Urine was mostly 144	
collected through clean catch midstream technique and as a random voided or first-morning 145	
sample in 56% of studies (15/27). Use of sterile containers was mentioned in ten out of 27 146	
studies. More details on urine sample collection, handling and storage, and the details of urine 147	
culture incubation can be found in Appendix 4. 148	
 149	
The overall quality of included studies was moderate (Figure 2). Twelve out of 27 studies gave 150	
a proper description of patients’ selection with the remaining not giving enough details to 151	
assess this methodological aspect of the study. There was no concern for risk of bias due to 152	
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index test implementation in over 80% of the studies (22/27). Similarly, for the reference 153	
standard except two studies, the performance of the urine culture was classified as high risk of 154	
bias. Flow and timing were described with sufficient details in one-third of studies (9/27). The 155	
high concern over the applicability of findings was due to the type of the reference standard in 156	
five studies and the index test in one case. The main concern in the case of the reference 157	
standard was the use of a double urine culture to confirm the diagnosis of bacterial infection. 158	
 159	
Twenty-one studies (9,491 women) reported accuracy data for the detection of nitrites using 160	
urine dipstick and eight for the combination of positive nitrites or leukocytes (5,940 women). 161	
The average prevalence of asymptomatic bacteriuria in these studies were 0.08 (95% CI 0.06 to 162	
0.10). The pooled sensitivity of urine dipstick for positive nitrites in detecting infection was 163	
0.55 (95% CI 0.42 to 0.67) with specificity 0.99 (95% CI 0.98 to 0.99). The pooled sensitivity 164	
of positive nitrites or leukocytes was 0.73 (95% CI 0.59 to 0.83) with specificity 0.89 (95% CI 165	
0.79 to 0.94). For both tests, the accuracy parameters were heterogeneous with greater 166	
variability in sensitivity than specificity (Figure 3), 95% prediction contour was visibly wider 167	
for the combined markers (Appendix 5). The likelihood ratio of the positive test result for the 168	
urine dipstick test using only nitrites marker was 54.1 (95% CI 26.5 to 266.21. 169	
 170	
One study each contributed data on the specificity and sensitivity of chlorhexidine reaction and 171	
uriscreen catalase tests. The sensitivity of the former was 1.00 (95% 0.65 to 1.00) and 172	
specificity (0.54, 95% CI 0.46 to 0.62) (Table 2). Use of Griess test to detect the presence of 173	
nitrites was reported in two studies (728 women). The sensitivity of the test was comparable to 174	
Uriscreen catalase test 0.65 (95% CI 0.50 to 0.78) with a specificity of 0.99 (95% CI 0.98 to 175	
1.00). The likelihood ratio of the positive test result was 56·6 (95% CI 12.6 to 255.1). Only one 176	
study reported the accuracy of the microscopic technique with the bacterial count in a 177	
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centrifuged urine sample with a clearly defined threshold of more than 20 bacteria per High 178	
Power Field (HPF). The sensitivity and specificity were 0.78 (95% CI 0.45 to 0.94) and 0.92 179	
(95% CI 0.88 to 0.94), respectively. 180	
 181	
Accuracy data of three dipslide-based tests included evaluation of Uricult (two studies), 182	
Microstix-3 (one study) and a generic dipslide method with gram stain dyeing and threshold of 183	
one or more bacteria per Oil Immersed Field (OIF) (six studies). Uricult had a sensitivity of 184	
0.92 (95% CI 0.69 to 1.00) and specificity 0.85 (95% CI 0.24 to 1.00). The dipslide with gram 185	
staining on uncentrifuged urine had sensitivity and specificity of 0.86 (95% CI 0.80 to 0.91) 186	
and 0.97 (95% CI 0.93 to 0.99) respectively (Figure 3). The likelihood ratio of the positive test 187	
result was 30.2 (95% CI 11.9 to 76.6). 188	
 189	
Sensitivity analysis was possible for dipstick with nitrites only as a marker, dipstick with 190	
nitrites or leukocytes and dipslide with gram staining. In all three cases, we explored the 191	
impact of population description and use of the sterile containers for urine storage. Neither of 192	
the factors changed the summary accuracy of the dipslide with gram staining. Analysis limited 193	
to studies with a clearly described population (asymptomatic women or not taking antibiotics) 194	
showed a marginal reduction in sensitivity (by 4%) for urine dipstick with positive leukocyte or 195	
nitrites marker. The pooled sensitivity of urine dipstick (nitrites with or without leukocytes) 196	
limited to studies providing details of urine container’s sterility, presented a minimal increase 197	
in parameter precision. Findings from studies with low risk of bias and studies where the type 198	
of urine sample was not properly described had a minimal impact on the sensitivity the dipstick 199	
test with no change in the value of the pooled specificity. 200	
 201	
Discussion 202	
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Out of 27 types of index tests identified in the literature, nine were suitable for use in the 203	
asymptomatic population. Three of them (urine dipstick, Griess test and dipslide with gram 204	
staining) had values of likelihood ratios for positive test result indicative of their usefulness 205	
(values > 10) in detecting asymptomatic bacteriuria during antenatal care. All test were minor 206	
to moderate usefulness to rule out the infection (likelihood ratios for the negative result 207	
between 0.5–0.1). 208	
 209	
This systematic review is a comprehensive and robust synthesis of accuracy data concerning 210	
on-site tests to detect asymptomatic bacteriuria during antenatal care. Prospectively registered 211	
protocol with pre-specified population, reference standard, and definition of the outcome 212	
informed study selection, data extraction, and analysis. On all stages of the review process, we 213	
followed current guidelines and standards.11 The literature search in electronic databases 214	
restricted to test accuracy studies due to pragmatic reasons was supplemented by manual 215	
reference check. The publication bias due to limitations of available statistical methods16, 17 216	
was not investigated in this review. However, we did undertake an extensive exploration of the 217	
heterogeneity between estimates of tests accuracy in individual studies. 218	
 219	
The main limitation of this review was poor reporting in individual studies and paucity of data. 220	
The quality assessment was hindered by insufficient reporting of characteristics or recruited 221	
women, their flow through the study and timing between the use of index test and reference 222	
standard. Empirical evidence showed that test accuracy estimates can be affected by flaws in 223	
study design and its conduct.14 The estimates of test accuracy for four included tests were 224	
based on data from single studies with small sample sizes.22-24 This makes the parameters less 225	
reliable (wide confidence intervals) and more prone to chance findings. In order to compare the 226	
accuracy of all identified tests, we used the univariate model to pool sensitivity and specificity 227	
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estimates when less than four studies were available. Even though this approach does not 228	
account for correlation between two parameters as in the bivariate model, the findings should 229	
be fairly similar.25 Despite these limitations our findings merit consideration as the most robust 230	
and current evidence synthesis. 231	
 232	
The prevalence of asymptomatic bacteriuria in included studies ranged from 2 – 23% which 233	
overlaps with previously reported range1. The likelihood ratios of the positive test result for the 234	
urine dipstick test (only nitrites), Griess test and generic dip slide with gram staining (bacterial 235	
count > 1/OIF) were indicative of tests usefulness in ruling in asymptomatic bacteriuria.21 The 236	
likelihood ratio of a positive result with Dipslide Uricult due to wide confidence intervals 237	
cannot be considered reliable. However, its likelihood ratio for the negative result was the only 238	
one indicative its usefulness to rule out the infection (< 0.1). Likelihood ratios can be used to 239	
help adapt the results of the findings to individual situation basing on Bayes’ theorem.26 With 240	
pretest probability derived from identified studies we calculate the posttest probability of 241	
having the infection with a positive and negative test result (Table 2). Two out of nine 242	
evaluated tests (urine dipstick with positive nitrites and Griess test) increased the probability 243	
from 8·0% to above 80.0% in case of positive result, and both reduced it by half in case of a 244	
negative result. Need for training and access to basic laboratory facilities might make Griess 245	
test and Gram staining less attractive than urine dipstick in resource-limited settings. 246	
 247	
Undetected and subsequently not treated asymptomatic bacteriuria is linked to pyelonephritis 248	
and other complications.3 Antibiotic treatment seem to reduce the risk of pyelonephritis in 249	
pregnancy and undesired pregnancy outcomes (preterm birth and low birth weight). Women 250	
incorrectly classified as positive (false positive) may be exposed to an unnecessary course of 251	
antibiotics with not well documented adverse effects.27 In light of lack of robust evaluation of 252	
12	
	
harms and increasing antimicrobial resistance, it is crucial to correctly identify women who 253	
will truly benefit from the treatment.8 254	
 255	
All identified on-site tests when positive increased posttest probability of detecting 256	
asymptomatic bacteriuria during the antenatal period. Urine dipstick, Griess test and dipslide 257	
with gram staining are most useful point-of-care options for ruling in the infection. Future 258	
research should aim to support the clinical decision-making on the management of 259	
asymptomatic pregnant women when access to urine culture is limited. 260	
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